Obermatt

Hana Pharm

KSC:293480 · KR7293480000
PharmaceuticalsSmall

360° View

88
Price/Sales49
Price/Earnings80
Price/Book34
Dividend Yield1
Revenue Growth97
Profit Growth81
Capital Growth84
TSR 52w32
Leverage46
Liquidity79
Refinancing74
Combined91
Analyst Opinions100
Pro Holdings14
Opinion Changes50
Market Pulse87

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees16
ISINKR7293480000
Last UpdateApr 2, 2026
Index & Theme
DermatologyEndocrinologyRespiratoryInflammationNeurologyCardiovascularPain ManagementCentral Nervous SystemHealth CareMedicalPharmaceutical

Description

Analysis

Hana Pharm's 360° View rank of 88 places it among the strongest overall — better than 88% of its true peers.

It's a growth standout (89) and reasonably valued (52). On safety it is very well financed (82), and the market shows favorable sentiment (63). Taken together, its Combined rank of 91 reads as among the strongest overall.

360° rank · history

1007550250
88
2026

All-time high

88

Jun 2026

All-time low

83

Mar 2026

Average rank

86

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
49
Price/Earnings
80
Price/Book
34
Dividend Yield
1
Value (overall)
52

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Hana Pharm with its peers
PharmGen Science
KSC:004720
74
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Samsung Pharm
KSC:001360
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kukje Pharma
KSC:002720
43
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Reyon Pharmaceutical
KSC:102460
16
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Samil Pharmaceutical
KSC:000520
28
CountrySouth Korea
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Korea United Pharm
KSC:033270
90
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →